cerrar
Tagged with R

CDE’s China Drug Evaluation Report 2020: Part 1
The following is an overview from Accestra Consulting* of Part 1 of China’s Center for Drug Evaluation (CDE)’s 2020 reporting, including data on…

Biosimilars & Biologics: China
Key legal info on biosimilars & biologics in China. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Localization: China
Want to know more about localization in China? Prepared in association with Fangda Partners, one of China’s most prestigious and well-regarded law…

Orphan Drugs & Rare Diseases: China
An intro to the legal situation for orphan drugs and rare diseases in China. Prepared in association with Fangda Partners, one of China’s most…

Cannabinoid Drugs, Medicinal Cannabis & Opioid Drugs: China
Cannabinoid drugs, medicinal cannabis & opioid drugs in India - a comprehensive legal overview. Prepared in association with Fangda Partners, one…

Regulatory Reforms: China
The key facts about regulatory reforms in Chinese pharma. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Patents & Trademarks: China
An outline of the legal situation around patents and trademarks for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…

Product Liability: China
A comprehensive guide to the legal implications around product liability in China. Prepared in association with Fangda Partners, one of China’s…

Traditional Medicines and OTC Products: China
A legal intro to traditional medicines and OTC products in China. Prepared in association with Fangda Partners, one of China’s most prestigious and…

Marketing, Manufacturing, Packaging & Labeling, Advertising:…
A brief overview of the situation regarding marketing, manufacturing, packaging & labeling and advertising within Chinese pharma. Prepared in…

Preclinical and Clinical Trial Requirements: China
The essential requirements for conducting preclinical and clinical trials in China. Prepared in association with Fangda Partners, one of China’s…

Regulatory, Pricing and Reimbursement: China
An intro to the regulatory, pricing and reimbursement scenario for pharmaceuticals in China. Prepared in association with Fangda Partners, one of…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here